https://scholars.lib.ntu.edu.tw/handle/123456789/528296
標題: | Fatal pneumonia and empyema thoracis caused by imipenem-resistant Nocardia abscessus in a cancer patient | 作者: | Lai C.-C. Tsai H.-Y. SHENG-YUAN RUAN Liao C.-H. PO-REN HSUEH |
公開日期: | 2015 | 卷: | 48 | 期: | 6 | 起(迄)頁: | 706-708 | 來源出版物: | Journal of Microbiology, Immunology and Infection | 摘要: | We describe a case of pneumonia and empyema thoracis caused by trimethoprim-sulfamethoxazole-susceptible, but imipenem-resistant Nocardia abscessus in a cancer patient. The isolate was confirmed to the species level by 16S rRNA sequencing analysis. The patient did not respond to antibiotic therapy, including ceftriaxone and imipenem, and died of progressing pneumonia and multiple organ failure. ? 2013 Taiwan Society of Microbiology. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/528296 | ISSN: | 1684-1182 | DOI: | 10.1016/j.jmii.2013.01.005 | SDG/關鍵字: | ceftriaxone; imipenem; sulfamethoxazole; trimethoprim; antiinfective agent; ceftriaxone; cotrimoxazole; imipenem; RNA 16S; acute respiratory failure; adult; antibiotic sensitivity; antibiotic therapy; Article; cancer patient; case report; crackle; empyema; empyema thoracis; fatality; fever; human; imipenem resistant Nocardia abscessus infection; laboratory test; male; middle aged; multiple organ failure; nocardiosis; physical examination; pleura effusion; pneumonia; pus; respiratory distress; shock; sputum culture; thorax pain; video assisted thoracoscopic surgery; drug effects; Empyema, Pleural; genetics; Hemangiosarcoma; immunocompromised patient; isolation and purification; microbiology; mortality; multidrug resistance; Nocardia; Nocardia Infections; pneumonia; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Empyema, Pleural; Hemangiosarcoma; Humans; Imipenem; Immunocompromised Host; Male; Middle Aged; Multiple Organ Failure; Nocardia; Nocardia Infections; Pneumonia; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。